values for children, adolescents
Angiotensin-converting enzyme (ACE; peptidyldipeptide hydrolase, EC 3.4.15.1), by virtue of its action on angiotensin I and bradykinin, plays a crucial role in blood-pressure regulation (1) . Attention was focused on this enzyme when Lieberman observed serum ACE to be increased in patients with sarcoidosis (2, 3) , findings confirmed and extended by others (4) (5) (6) (7) (8) . Despite its lack of specificity serum ACE has been reported as a sensitive index for assessing clinical status and monitoring the effect of therapy in the management of sarcoidosis (9) (10) (11) .
Numerous methods for determining ACE activity, using both physiological and model substrates, have been described (1) . Commonly, in clinical studies the synthetic substrate hippuryl-L-histidyl-L-leucine (HHL) has been used to measure serum ACE. The enzyme hydrolyzes this molecule to give hippurate, which can be extracted and measured spectrophotometrically (12) , and histidylleucine, which can be measured by fluorometry after reaction with a fluorescent adduct (13, 14) . Because histidylleucine is further hydrolyzed by a peptidase in serum (13) , those procedures that quantify serum ACE in terms of histidylleucine production are potentially subject to error. Previous workers (13) found the spectrophotometrk assay insensitive and imprecise, owing to the low molar absorptivity of hippuric acid and interference from serum lipids in the extraction step. Furthermore, phosphate has hitherto been used as the reaction buffer in serum ACE assays, although phosphate is a known inhibitor of human serum ACE (15).
Here we describe an optimized assay for ACE in human serum in which cyanuric chloride (2,4,6-trichloro-striazine)/dioxan is used as the reagent, reacting with hippurate in the presence of phosphate buffer to yield a chromogen that is quantified from its absorbance at 382 nm (16). Previously, the reagent has been used to assay ACE from rat lung (17). Table 1 . The absorption maximum of the spectrum was confirmed to be at 382 nm and the millimolar absorptivity of the chromogen was calculated to be 33.5 L mmol' cmt.
Materials and Methods

Apparatus
Optimum Conditions for the Enzyme Reaction
Buffer and pH. Of those buffers tested, serum ACE activity was highest in borate buffer (Table 2) . A detailed experiment in which we used phosphate and borate buffers between pH 7.0 and pH 9.5 showed that activity was maximum in borate buffer, pH 8.3-8.5 (Figure 3) detectable but low ( Figure 5 ). Activity was greatest with a sodium chloride concentration of 800 mmol/L in the incubation mixture.
Thus, final concentrations in the optimized incubation mixture are, per liter: 80 mmol of boric acid! NaOH buffer, pH 8.3, 800 mmol of NaC1, and 4 mmol of HHL.
Performance of the Optimized Assay
Linearity.
Formation of hippurate was linearly related to time. For the optimized assay an incubation interval of 15 mm was chosen. This results in good sensitivity and precision within the normal range while allowing sera with ACE activity up to threefold the upper limit of normal to be assayed without. dilution. We prepared dilutions of a serum pool supplemented with human lung extract with an albumin/saline diluent (bovine serum albumin, 50 g/L; NaCI, 145 mmol/L) and analyzed for ACE activity. Activity was plotted vs dilution factor ( Figure 6 ). Linear regression analysis gave: slope = 208, intercept = -0.77 U/L, r = 0.9991, and a standard error of estimate (S,) of 2.7 U/L. Linearity extends to at least 200 U/L (i.A 382 nm = 2.01), above which the quality of the spectrophotometer becomes the limiting factor.
Precision.
We assayed serum pools with normal and above-normal activities, to estimate the variability of the method. The results (Table 3) show good precision.
Tests for interference.
The assay is unaffected by bilirubin: when serial dilutions of an icteric serum pool (bilirubin = 240 tmol/L, ACE = 45 UIL) were prepared in the albumin/saline diluent, ACE activity was linearly related to dilution. Linear regression analysis gave the equation y = 1.027x -0.89 (where y is the measured ACE activity and x is the expected value), r = 0.9996, and = 0.5 U/L. A similar linear dilution effect was observed with a lipemic and turbid serum pool (cholesterol = 9.2 mmol/L, triglyceride = 9.4 mmol/L, ACE = 61 UIL). Linear regression statistics were y = 1.025x -1.73, r = 0.9997, and = 0.5 U./L. To test the effect of hemolysis on the procedure, we added 0.1-mL aliquots of freshly prepared hemolysates to 0.9 mL of serum pool, then assayed for ACE activity. Conditions compatible with gross hemolysis (3-6 g Hb per liter) resulted in 5-10% negative interference.
Reference Intervals
Serum specimens were from 229 adult subjects (laboratory staff and hospital patients). On the basis of clinical particulars received, the patients selected had no history of disorders believed to disturb serum ACE. There were 117 men, ranging in age from 21 to 82 years (mean age = 46.7 years), and 112 women, ranging in age from 20 to 92 years (mean age = 46.7).
Reference intervals were determined by using the 2.5 to 97.5 percentile nonparametric range (18). Estimates of mean, standard deviation, skewness, kurtosis, and the 5th and 95th percentile values are shown in Table 4 . Serum specimens from 36 patients (17 male, 19 female) ranging in age from 4-19 years (mean age = 14.8 years) were also analyzed. The mean activity of these subjects was 51.8 U/L with an SD of 19.3 U/L.
Discussion
Previous assays for human serum ACE activity (3, 13) 
